Home page  |  Help  |  Clear
English  |  French
 Search  |  Categories  |  Titles A-Z  |  Countries  |  Compare countries  |  Index  
Full TOC
Expand Document
Expand Chapter
Preferences

close this bookA Short Information Manual on: The Tanzania National Drug Policy, The Master Plan for the Pharmaceutical Sector 1992-2000 Tanzania Mainland - A Summary, Hospital Therapeutic Committees (WHO; 1993; 42 pages)
View the documentForeword
Open this folder and view contentsA. The Tanzania National Drug Policy
close this folderB. The Masterplan for the Pharmaceutical Sector of Tanzania Mainland 1992 - 2000
View the document1. Introduction
View the document2. Central Medical Stores (CMS)
View the document3. Pharmaceuticals and Supplies Unit (PSU)
close this folder4. Pharmacy Board
View the document4.1. General
View the document4.2. Drug Legislation
View the document4.3. Drug Registration
View the document4.4. Drug Inspection
View the document4.5. Drug Information
View the document4.6. Drug Advertising and Promotion
View the document5. Drug Quality Assurance and Control
View the document6. Local Production of Pharmaceutical Products
View the document7. Traditional Medicine
View the document8. Local Financing of Drugs
View the document9. Conclusions
Open this folder and view contentsC. Hospital Therapeutic Committees
 

4.4. Drug Inspection

An already existing Drug Inspection Unit is responsible for the inspection of all drug production and distribution enterprises, including importers, manufacturers, wholesalers and retail establishments. The activities of this unit will be gradually developed to cover the whole country. The unit will support the development of appropriate standards for the various types of enterprises (private as well as public establishments in the pharmaceutical sector). It will give support to their implementation and subsequently enforce adherence to them.

Important part will be the development of local Tanzanian Good Manufacturing Practise standards (GMP) to enable GMP certification of the local industries. Inspectors will be trained to adequately implement and maintain certification strategies to ensure drug quality. This is not only important for the local drug market, but also a prerequisite for export of Pharmaceuticals within the framework of the WHO Certification Scheme.

The capacity of the Drug Inspection Unit will be increased to enable better monitoring of the drug market in Tanzania. It is envisaged to implement zonal drug inspection offices, particularly in border areas.

to previous sectionto next section

Please provide your feedback English  |  French